Cargando…

Fluoroquinolone-resistant Escherichia coli in intestinal flora of patients undergoing transrectal ultrasound-guided prostate biopsy – possible shift in biopsy prophylaxis

INTRODUCTION: Infection of prostate gland following biopsy is common complication. Most common pathogen is E.coli. Since fluorochinolones are commonly prescribed as prophylaxis, infection caused by E.coli leads to complicated infections, especially due to fluoroquinolone-resistant species. The aim o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Adamczyk, Przemysław, Juszczak, Kajetan, Prondzinska, Małgorzata, Kędzierska, Anna, Szwajkert-Sobiecka, Hanna, Drewa, Tomasz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Polish Urological Association 2017
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5510333/ https://www.ncbi.nlm.nih.gov/pubmed/28721289 http://dx.doi.org/10.5173/ceju.2017.739

Ejemplares similares

Fluoroquinolone-based antimicrobial prophylaxis in patients undergoing transrectal ultrasound-guided prostate biopsy
por: Sieczkowski, M., et al.
Publicado: (2015)

Trial Comparing a Combined Regimen of Amikacin and Ciprofloxacin to Ciprofloxacin Alone as Transrectal Prostate Biopsy Prophylaxis in the Era of High Fluoroquinolone-Resistant Rectal Flora
por: Son, Kyung Chul, et al.
Publicado: (2018)

Comparison of a combined regimen of fosfomycin and ciprofloxacin with ciprofloxacin alone as antimicrobial prophylaxis for transrectal prostate biopsy in the era of high fluoroquinolone-resistant rectal flora
por: Lim, Do Gyeong, et al.
Publicado: (2021)

Efficacy of Combination Use of Beta-Lactamase Inhibitor with Penicillin and Fluoroquinolones for Antibiotic Prophylaxis in Transrectal Prostate Biopsy
por: Shigemura, Katsumi, et al.
Publicado: (2011)

Comparison of Single and Prolonged Fluoroquinolone Prophylaxis and Risk Factors for Infectious Complications After Transrectal Prostate Biopsy
por: Kalkanlı, Arif, et al.
Publicado: (2018)

Comparison of Fluoroquinolones and Other Antibiotic Prophylaxis Regimens for Preventing Complications in Patients Undergoing Transrectal Prostate Biopsy
por: Tulone, Gabriele, et al.
Publicado: (2022)

Antibiotic prophylaxis with intravenous ceftriaxone and fluoroquinolone reduces infectious complications after transrectal ultrasound-guided prostatic biopsy
por: Lee, Chunwoo, et al.
Publicado: (2015)

Fluoroquinolone-Resistant Escherichia coli Infections After Transrectal Biopsy of the Prostate in the Veterans Affairs Healthcare System
por: Saade, Elie A., et al.
Publicado: (2016)

Drug-Eluting Biopsy Needle as a Novel Strategy for Antimicrobial Prophylaxis in Transrectal Prostate Biopsy
por: Sieczkowski, Marcin, et al.
Publicado: (2017)

Molecular genetic testing does not improve the detection of fluoroquinolone resistance before transrectal prostate biopsy
por: Liss, Michael A., et al.
Publicado: (2022)

The molecular mechanisms of fluoroquinolone resistance found in rectal swab isolates of Enterobacterales from men undergoing a transrectal prostate biopsy: the rationale for targeted prophylaxis
por: Piekarska, Katarzyna, et al.
Publicado: (2021)

Robot-assisted radical cystectomy – first Polish clinical outcomes
por: Adamczyk, Przemysław, et al.
Publicado: (2017)

Monoprophylaxis With Cephalosporins for Transrectal Prostate Biopsy After the Fluoroquinolone-Era: A Multi-Institutional Comparison of Severe Infectious Complications
por: Wenzel, Mike, et al.
Publicado: (2021)

Clinical Impact of Fluoroquinolone-Resistant Escherichia coli in the Fecal Flora of Hematological Patients with Neutropenia and Levofloxacin Prophylaxis
por: Chong, Yong, et al.
Publicado: (2014)

Quinolone Prophylaxis in Transrectal Ultrasound Guided Prostate Biopsy: An Eight-Year Single Center Experience
por: Chiang, Bing-Juin, et al.
Publicado: (2013)

Fosfomycin antimicrobial prophylaxis for transrectal ultrasound-guided biopsy of the prostate: A prospective randomised study
por: Fahmy, Ahmed M., et al.
Publicado: (2016)

The Efficacy of Fosfomycin as Antibiotic Prophylaxis for Transrectal Prostate Biopsy and Impact on Lower Urinary Tract Symptom After Biopsy: A Prospective Study
por: Cardoso, Andreia, et al.
Publicado: (2023)

The presence of LUTS is not a decisive tool for deciding who should be qualified for prostate biopsy
por: Juszczak, Kajetan
Publicado: (2014)

Transperineal vs. transrectal biopsy in MRI targeting
por: Grummet, Jeremy, et al.
Publicado: (2017)

Inflammatory changes in biopsy specimens from patients with suspected prostate cancer
por: Adamczyk, Przemysław, et al.
Publicado: (2013)

Occurrence and significance of fluoroquinolone-resistant and ESBL-producing Escherichia coli and Klebsiella pneumoniae complex of the rectal flora in Ghanaian patients undergoing prostate biopsy
por: Labi, Appiah-Korang, et al.
Publicado: (2022)

Urological procedures in Central Europe and the current reality based on the national registries of Czech Republic, Hungary, and Poland (2012 status)
por: Adamczyk, Przemysław, et al.
Publicado: (2016)

Evaluation of targeted antimicrobial prophylaxis for transrectal ultrasound guided prostate biopsy: a prospective cohort trial
por: Zembower, Teresa R., et al.
Publicado: (2017)

“Targeted” prophylaxis: Impact of rectal swab culture-directed prophylaxis on infectious complications after transrectal ultrasound-guided prostate biopsy
por: Singh, Prabhjot, et al.
Publicado: (2017)

Infectious complications after transrectal MRI-targeted and systematic prostate biopsy
por: Kalalahti, Inari, et al.
Publicado: (2022)

Value of transrectal ultrasound-guided biopsy in endoscopy negative biopsy patients with rectal lesions
por: Li, Tingting, et al.
Publicado: (2023)

Impact of preoperative screening for rectal colonization with fluoroquinolone-resistant enteric bacteria on the incidence of sepsis following transrectal ultrasound guided prostate biopsy
por: Farrell, John J, et al.
Publicado: (2017)

The future perspectives in transrectal prostate ultrasound guided biopsy
por: Hwang, Sung II, et al.
Publicado: (2014)

Infection after transrectal ultrasound-guided prostate biopsy
por: Lee, Seung-Ju
Publicado: (2015)

Rebiopsy rate after transperineal or transrectal prostate biopsy
por: Marenco Jimenez, Jose L., et al.
Publicado: (2021)

Effectiveness of fosfomycin-based antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy: A Korean multicenter study
por: Lim, Do Gyeong, et al.
Publicado: (2023)

Fosfomycin for Antibiotic Prophylaxis in Men Undergoing a Transrectal Prostate Biopsy: A Systematic Review and Meta-Analysis
por: Gu, Hui Mo, et al.
Publicado: (2023)

Incomplete recovery of the fecal flora of hematological patients with neutropenia and repeated fluoroquinolone prophylaxis
por: Chong, Yong, et al.
Publicado: (2017)

Evaluation of periprocedure antibiotics and infection-related hospitalizations after transrectal prostate biopsies
por: Ryan, Tenley, et al.
Publicado: (2022)

Comparison of systematic randomized 12-core transrectal ultrasonography-guided prostate biopsy with magnetic resonance imaging-transrectal ultrasonography fusion-targeted prostate biopsy
por: Song, Byeongdo, et al.
Publicado: (2022)

Age and risk of major complications in patients undergoing radical cystectomy for muscle invasive bladder cancer
por: Adamczyk, Przemyslaw, et al.
Publicado: (2021)

MRI-Targeted Biopsies versus Systematic Transrectal Ultrasound Guided Biopsies for the Diagnosis of Localized Prostate Cancer in Biopsy Naïve Men
por: Peltier, Alexandre, et al.
Publicado: (2015)

Transrectal povidone-iodine efficiency in reducing infections occurring after transrectal ultrasound guided biopsy of the prostate
por: Siyez, Ender
Publicado: (2021)

Risk Factors for Acute Prostatitis after Transrectal Biopsy of the Prostate
por: Kim, Sang Jin, et al.
Publicado: (2010)

Microbiological Characteristics of Acute Prostatitis After Transrectal Prostate Biopsy
por: Bang, Jun-Ho, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_64nqur6q990e0ths7ae1d3tidb